CCNA2 and breast carcinoma: Interestingly, the analysis of gene expression databases of different cohorts of breast cancer patients reveals that those expressing high levels of PLK1, BUB1 or CCNA2 exhibit lower disease-free survival when compared to those expressing low levels (Fig 5A).